Quick Answer
COLLEGIUM PHARMACEUTICAL, INC reported R&D Expense of $0.00 for fiscal year 2024.
COLLEGIUM PHARMACEUTICAL, INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $0.00 | — |
| 2023 | $0.00 | -100.0% |
| 2022 | $3.98M | -57.9% |
| 2021 | $9.45M | -3.3% |
| 2020 | $9.77M | -5.5% |
| 2019 | $10.34M | +19.4% |
| 2018 | $8.66M | +1.0% |
| 2017 | $8.57M | -42.7% |
| 2016 | $14.95M | +87.4% |
| 2015 | $7.97M | -46.7% |
| 2014 | $14.96M | +5.7% |
| 2013 | $14.16M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| June 30, 2022 | $0.00 | -100.0% | -100.0% |
| March 31, 2022 | $3.98M | +35.9% | +174.7% |
| September 30, 2021 | $1.45M | -32.3% | -58.1% |
| June 30, 2021 | $3.46M | +38.9% | +18.2% |
| March 31, 2021 | $2.93M | +9.9% | +36.9% |
| September 30, 2020 | $2.14M | -14.1% | -14.1% |
| June 30, 2020 | $2.49M | +1.4% | -6.5% |
| March 31, 2020 | $2.67M | -10.9% | +7.0% |
- Over the 2013–2024 period, COLLEGIUM PHARMACEUTICAL, INC’s r&d expense has declined by 100.0% (from $14.16 million to $0.00).
- The most recent figure is from COLLEGIUM PHARMACEUTICAL, INC’s fiscal year 2024 report (Form 10-K), filed with the SEC on February 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: